Marie-Hélène Laverriere

Marie-Hélène Laverriere

Auto-generated profile, based on publicly available information

Marie-Hélène Laverriere

Team Mechanobiology, Immunity and Cancer, Institute for Advanced Biosciences Inserm 1209 – UMR CNRS 5309, Grenoble, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
MMMarie Malier
Marie Malier
KGKhaldoun Gharzeddine
Khaldoun Gharzeddine
MLMarie-Hélène Laverriere
Marie-Hélène Laverriere
SMSabrina Marsili
Sabrina Marsili
FTFabienne Thomas
Fabienne Thomas
Arnaud MilletArnaud Millet
Arnaud Millet
Colorectal adenocarcinoma is a leading cause of death worldwide, and immune infiltration in colorectal tumors has been recognized recently as an important pathophysiologic event. In this context, tumor-associated macrophages (TAM) have been related to chemoresistance to 5-fluorouracil (5-FU), the first-line chemotherapeutic agent used in treating colorectal cancers. Nevertheless, the details of this chemoresistance mechanism are still poorly elucidated. In the current study, we report that macrophages specifically overexpress dihydropyrimidine dehydrogenase (DPD) in hypoxia, leading to macrophage-induced chemoresistance to 5-FU via inactivation of the drug. Hypoxia-induced macrophage DPD expression was controlled by HIF2α. TAMs constituted the main contributors to DPD activity in human colorectal primary or secondary tumors, while cancer cells did not express significant levels of DPD. In addition, contrary to humans, macrophages in mice do not express DPD. Together, these findings shed light on the role of TAMs in promoting chemoresistance in colorectal cancers and identify potential new therapeutic targets.Significance: Hypoxia induces HIF2α-mediated overexpression of dihydropyrimidine dehydrogenase in TAMs, leading to chemoresistance to 5-FU in colon cancers.

4 April 2023
Verified
Other
Open access
MMMarie Malier
Marie Malier
KGKhaldoun Gharzeddine
Khaldoun Gharzeddine
MLMarie-Hélène Laverriere
Marie-Hélène Laverriere
SMSabrina Marsili
Sabrina Marsili
FTFabienne Thomas
Fabienne Thomas
Arnaud MilletArnaud Millet
Arnaud Millet
Supplementary figures S1 to S7

4 April 2023
Verified
Other
Open access
MMMarie Malier
Marie Malier
KGKhaldoun Gharzeddine
Khaldoun Gharzeddine
MLMarie-Hélène Laverriere
Marie-Hélène Laverriere
SMSabrina Marsili
Sabrina Marsili
FTFabienne Thomas
Fabienne Thomas
Arnaud MilletArnaud Millet
Arnaud Millet

4 April 2023
Verified
Other
Open access
MMMarie Malier
Marie Malier
KGKhaldoun Gharzeddine
Khaldoun Gharzeddine
MLMarie-Hélène Laverriere
Marie-Hélène Laverriere
SMSabrina Marsili
Sabrina Marsili
FTFabienne Thomas
Fabienne Thomas
Arnaud MilletArnaud Millet
Arnaud Millet

4 April 2023
Verified
Other
Open access
MMMarie Malier
Marie Malier
KGKhaldoun Gharzeddine
Khaldoun Gharzeddine
MLMarie-Hélène Laverriere
Marie-Hélène Laverriere
SMSabrina Marsili
Sabrina Marsili
FTFabienne Thomas
Fabienne Thomas
Arnaud MilletArnaud Millet
Arnaud Millet
Colorectal adenocarcinoma is a leading cause of death worldwide, and immune infiltration in colorectal tumors has been recognized recently as an important pathophysiologic event. In this context, tumor-associated macrophages (TAM) have been related to chemoresistance to 5-fluorouracil (5-FU), the first-line chemotherapeutic agent used in treating colorectal cancers. Nevertheless, the details of this chemoresistance mechanism are still poorly elucidated. In the current study, we report that macrophages specifically overexpress dihydropyrimidine dehydrogenase (DPD) in hypoxia, leading to macrophage-induced chemoresistance to 5-FU via inactivation of the drug. Hypoxia-induced macrophage DPD expression was controlled by HIF2α. TAMs constituted the main contributors to DPD activity in human colorectal primary or secondary tumors, while cancer cells did not express significant levels of DPD. In addition, contrary to humans, macrophages in mice do not express DPD. Together, these findings shed light on the role of TAMs in promoting chemoresistance in colorectal cancers and identify potential new therapeutic targets.Significance:Hypoxia induces HIF2α-mediated overexpression of dihydropyrimidine dehydrogenase in TAMs, leading to chemoresistance to 5-FU in colon cancers.

4 April 2023
Verified
Other
Open access
MMMarie Malier
Marie Malier
KGKhaldoun Gharzeddine
Khaldoun Gharzeddine
MLMarie-Hélène Laverriere
Marie-Hélène Laverriere
SMSabrina Marsili
Sabrina Marsili
FTFabienne Thomas
Fabienne Thomas
Arnaud MilletArnaud Millet
Arnaud Millet
Supplementary materials and supplementary figure legends